HomeNX1 • ASX
add
Nexalis Therapeutics Ltd
Previous close
$0.024
Year range
$0.020 - $0.029
Market cap
7.29M AUD
Avg Volume
94.49K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 102.42K | -26.95% |
Operating expense | 552.06K | 26.35% |
Net income | -487.46K | -106.64% |
Net profit margin | -475.95 | -182.88% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 436.90K | 124.15% |
Total assets | 1.21M | 69.59% |
Total liabilities | 2.38M | 206.96% |
Total equity | -1.18M | — |
Shares outstanding | 239.36M | — |
Price to book | ∞ | — |
Return on assets | -93.04% | — |
Return on capital | 259.18% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -487.46K | -106.64% |
Cash from operations | -463.54K | -178.93% |
Cash from investing | — | — |
Cash from financing | 441.33K | 353.46% |
Net change in cash | -22.21K | 67.75% |
Free cash flow | -299.83K | -63.56% |
About
Founded
2016
Website
